Interestingly, serum CCL25, which is the only natural ligand for CCR9, was also significantly elevated in NSCLC patients compared to controls, suggesting the clinical significance of CCR9/CCL25 in LuCa. Here, CCR9 is linked to non-small cell lung carcinoma.